Labcorp Cash Flow Statement
NYSE: LHHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Labcorp free cash flow
In fiscal 2025, Labcorp generated $1.64 billion of operating cash flow and spent $434.5 million on capital expenditures. That left free cash flow of $1.21 billion, a free-cash-flow margin of 8.6% of revenue. Free cash flow was up 10.0% from the prior year's $1.10 billion.
Labcorp returned $690.7 million to shareholders: $240.7 million in dividends and $450.0 million in share repurchases, equal to 57% of free cash flow. Free cash flow covered dividend payments 5.0 times.
Summary generated from market data by MetaCap's automated system. Methodology
Labcorp cash flow statement (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20212022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 877.70M | 747.10M | 419.20M | 1.28B | 2.38B | 1.56B | 824.90M | 883.90M | 1.23B | 712.90M |
| Net Income growth (YoY) | +17.48% | +78.22% | -67.27% | -46.18% | +52.83% | +88.75% | -6.67% | -28.31% | +72.94% | +62.50% |
| Depreciation & Amortization | 681.10M | 643.50M | 577.30M | 537.20M | 577.00M | 624.70M | 577.20M | 552.10M | 533.20M | 499.20M |
| Stock-Based Compensation | 125.80M | 116.70M | 128.70M | 116.80M | 132.90M | 111.70M | 107.00M | 91.60M | 109.70M | 109.60M |
| Change in Working Capital | -199.10M | -71.90M | -67.20M | 598.30M | 227.20M | -1.07B | -103.30M | -17.10M | 221.10M | -109.60M |
| Operating Cash Flow | 1.64B | 1.59B | 1.33B | 1.96B | 3.11B | 2.14B | 1.44B | 1.31B | 1.50B | 1.20B |
| Capital Expenditures | -434.50M | -489.90M | -453.60M | -429.30M | -421.50M | -381.70M | -400.20M | -379.80M | -312.90M | -278.90M |
| Investing Cash Flow | -1.19B | -1.37B | -1.17B | -1.65B | -884.60M | -643.20M | -1.28B | 206.70M | -2.23B | -795.70M |
| Dividends Paid | -240.70M | -243.10M | -254.00M | -195.20M | 0 | 0 | — | — | — | — |
| Share Repurchases | -450.00M | -250.10M | -1.00B | -1.10B | -1.67B | -100.00M | -450.00M | -700.00M | -338.10M | -43.90M |
| Debt Issued | 0 | 2.00B | 0 | 0 | 1.00B | 0 | 1.05B | 0 | 1.20B | 0 |
| Debt Repaid | -1.00B | -1.00B | -300.00M | 0 | -1.00B | -412.20M | -687.90M | -400.00M | -500.10M | -454.70M |
| Financing Cash Flow | -1.46B | 779.90M | -59.30M | -1.32B | -2.07B | -517.40M | -252.70M | -1.39B | 593.20M | -671.00M |
| Net Change in Cash | -986.40M | 981.90M | 106.80M | -1.04B | 151.90M | 983.30M | -89.30M | 110.20M | -116.90M | -282.80M |
| Free Cash Flow | 1.21B | 1.10B | 874.10M | 1.53B | 2.69B | 1.75B | 1.04B | 925.60M | 1.19B | 918.20M |
This table shows 10 annual periods of Labcorp's cash flow statement, from FY 2025 back to FY 2016, across 14 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow LH's reporting calendar. What is a cash flow statement?